Inhaled Drug Delivery Specialist

4/4 By invite only and extremely limited in numbers; attendees are encouraged to apply to join now! Learn how to consolidate your inhalation portfolio at InsipreMe Soft Mist San Diego 2020. #ReduceRisk #ReduceCost #IncreaseSuccess

3/4 Topics include: Update yourself on the regulatory and pharmaceutical trends. Meet and network with KOLs, industry leaders and experts. Meet the key suppliers of the development process: device, formulation, analytical tools, industrialization, leachables and extractables.

1/4 Join us at InspireMe Soft Mist San Diego 2020. This event will be a compact journey through the development process of SMis and you are invited! To learn how to consolidate your inhalation portfolio, apply to register to attend this SMi Workshop: [email protected]

Happy New Year 2020. Visions of research danced in their heads. If you'll indulge a bit of shop talk, 2019 was about 2 things: 1) Making the World Healthier one Breath at a Time. 2) Redefining Inhaler Technologies. What do we have in store for 2020? Generic Ellipta: Oh MY!

Follow these 3 steps to choose a DPI Device Just like a famous waltz, we have created the perfect 3 steps to choose a DPI device, so you can dance your way to the perfect Inhaler strategy. Read it here: lnkd.in/duGtV85 #ReduceCost #ReduceRisk #IncreaseSuccess #device

FDA approves MRX001 “the OGD’s preliminary review is that the information and devices submitted suggest that your proposed device constituent may be appropriate for submission as part of an ANDA referencing ADVAIR DISKUS” linkedin.com/feed/update/urn…

Happy 3rd Birthday Merxin Ltd! What fun, what a team !

MRX001 achieves in vitro BE against Advair Diskus. MRX001, Full invitro BE for MRX001 vs Advair Diskus 250/50 at 60 L/min. Next move: we are adapting MRX001 to match Elipta. Why not! we are half way there already

非常期待本周在南京举办的IDDA2018会议上与大家见面。同时我也很荣幸被邀请来做吸入治疗设备和相关病人主题的演讲。此讲座将会在10月20日星期六上午举行。即将参加IDDA2018各位同仁，如果您想了解更多关于如何让吸入治疗设备及市场现状的信息，我们可以在会议期间有进一步的沟通

We have signed up our softmist inhaler MRX004 with a worldwide exclusive deal for tiotropium and olodaterol. The partnership will see the development of this 505j generic device for COPD. We are delighted with this partnership and the trust that our clients have in our work.

You dreamed It, We made It: MRX004, softmist inhaler: The Video. Enjoy and Spread the News.

Inhalation Insights Kuala Lumpur: 5 July 2018 Learn the 7 secrets to a successful DPI filing @NanopharmTweets inhalation-insights.com/

Don't miss this week seminar on Inhaled Drug Delivery Products: How expensive is it to develop a generic inhaled product? THE SYMPOSIUM: LEADING THE WAY IN MICRO-DOSING DPIS BOLOGNA, APRIL 11-12, 2018. lnkd.in/gMzZXai

GSK Trelegy Ellipta: Forecasting Its Evolution aedestra.com/blog/gsk-treleg…

Delighted to have had the opportunity to welcome HRH the Duke Of York to the new MERXIN Ltd headquarters at KLIC. Very grateful for His support to UK science and technology. Thank you for your visit Sir. @TheDukeOfYork edp24.co.uk/news/duke-of-yor…